Status:
COMPLETED
Effect of Metformin in Children With Type 1 Diabetes
Lead Sponsor:
Ain Shams University
Conditions:
Effect of Change in T1DM Glycemic Control
Eligibility:
All Genders
7-18 years
Phase:
PHASE2
PHASE3
Brief Summary
Cardiovascular disease is the leading cause of mortality in type 1 diabetes mellitus (T1DM). Vascular dysfunction is an early and critical event in the development of cardiovascular disease. Children ...
Detailed Description
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by T-cell mediated destruction of the pancreatic b-cells, resulting in insulin deficiency and elevated blood glucose levels. The...
Eligibility Criteria
Inclusion
- Patients with type 1 diabetes mellitus (5 years duration at least) and with micro-vascular complications.
- Patients on regular visits to clinic.
- Patients on regular insulin therapy.
Exclusion
- Any clinical evidence of infection, hematological diseases, tumors, liver dysfunction, urinary tract disorders, connective tissue disease, or other autoimmune diseases.
Key Trial Info
Start Date :
February 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 29 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04879511
Start Date
February 10 2018
End Date
January 29 2021
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nancy Elbarbary
Cairo, Egypt, 11361